| HOME | HELP | E-MAIL ALERTS | SEARCH |
|
PEDIATRICS Vol. 119 No. 1 January 2007, pp. 207-208 (doi:10.1542/peds.2006-3309)
POLICY STATEMENT |
The annual recommended immunization schedules for children and adolescents in the United States for 2007 were approved by the American Academy of Pediatrics, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention, and the American Academy of Family Physicians. These schedules reflect current recommendations for use of vaccines licensed by the US Food and Drug Administration. In view of the increasing complexity of the immunization schedule, the 2007 recommendations for children and adolescents have been divided into 2 separate schedules: one for children 0 to 6 years of age and one for those 7 to 18 years of age.
The 2007 schedules reflect the following major changes:
Clinically significant adverse events that follow immunization should be reported to the Vaccine Adverse Event Reporting System (VAERS). Guidance about how to obtain and complete a VAERS form can be obtained on the Internet at www.vaers.hhs.gov or by calling 800-822-7967. Information on new vaccine releases, vaccine supplies, and statements on specific vaccines can be found at www.aap.org and www.cdc.gov/nip. Vaccine-related updates are available online at www.aapredbook.org.
| Committee on Infectious Diseases, 20062007 |
|---|
|
|
|---|
Robert S. Baltimore, MD
Henry H. Bernstein, DO
John S. Bradley, MD
Michael T. Brady, MD
Penelope H. Dennehy, MD
Margaret C. Fisher, MD
Robert W. Frenck Jr, MD
David W. Kimberlin, MD
Sarah S. Long, MD
Julia A. McMillan, MD
Lorry G. Rubin, MD
| Liaisons |
|---|
|
|
|---|
American Academy of Family Physicians
Marc A. Fischer, MD
Centers for Disease Control and Prevention
Richard L. Gorman, MD
National Institutes of Health
Douglas R. Pratt, MD
Food and Drug Administration
Anne Schuchat, MD
Centers for Disease Control and Prevention
Benjamin Schwartz, MD
National Vaccine Program Office
Jeffrey R. Starke, MD
American Thoracic Society
Jack Swanson, MD
Practice Action Group
| Ex Officio |
|---|
|
|
|---|
Red Book Editor
| Consultant |
|---|
|
|
|---|
| Staff |
|---|
|
|
|---|
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
The following policy statement is a revision:
The following policy statement has been revised:
This article has been cited by other articles:
![]() |
M. J. Smith, S. S. Ellenberg, L. M. Bell, and D. M. Rubin Media Coverage of the Measles-Mumps-Rubella Vaccine and Autism Controversy and Its Relationship to MMR Immunization Rates in the United States Pediatrics, April 1, 2008; 121(4): e836 - e843. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Roush, T. V. Murphy, and and the Vaccine-Preventable Disease Table Working Historical Comparisons of Morbidity and Mortality for Vaccine-Preventable Diseases in the United States JAMA, November 14, 2007; 298(18): 2155 - 2163. [Abstract] [Full Text] [PDF] |
||||
![]() |
Committee on Infectious Diseases Prevention of Human Papillomavirus Infection: Provisional Recommendations for Immunization of Girls and Women With Quadrivalent Human Papillomavirus Vaccine Pediatrics, September 1, 2007; 120(3): 666 - 668. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | E-MAIL ALERTS | SEARCH |